Work through the two axes. Targeting: the response is not aimed at a harmless allergen, and there is no single self antigen clearly identified, but the presence of circulating immune complexes means antibody is binding antigen in the fluid phase and the complexes are depositing in tissue. That is misdirection in the sense that the damage is not directed at a useful target, but the more specific reading is that the effector step, immune complex deposition with complement consumption, is what is injuring the body. Regulation: there is no evidence of a self-amplifying cytokine loop; the fever and rash are consistent with complement activation and complex deposition rather than a runaway cytokine feedback cycle. The failed checkpoint is therefore not a tolerance checkpoint in the sense of a self-reactive clone escaping, and not the negative regulation of a cytokine loop. The most defensible classification is an immune-complex-mediated effector injury, where the targeting is misdirected and the amplification is bounded.
The mechanism also suggests where the process could be interrupted. Since the injury is driven by circulating complexes and complement, the relevant joints are the formation of the complexes, their deposition in tissue, and the complement activation that amplifies the damage. Removing the original pathogen would not help, because the pathogen is no longer present. This is the same reasoning pattern used earlier: identify the failed checkpoint, then read the intervention points off the structure of the pathway.
The evidence given is not enough to name a specific disease, and the classification could change if further data showed, for example, a self-reactive antibody or an active cytokine loop. The value of the exercise is the reasoning pattern, not the label.